Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
International Immunopharmacology
|
February 26, 2026
Cyclophosphamide-pomalidomide combination alters the tumour cell secretome and enhances the anti-myeloma activity of elotuzumab through NK cell-mediated cytotoxicity
Claire L Feerick, Lei Lei, Dawn Swan, et al.
Plos One
|
August 11, 2012
Adenoviral transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation
Oliver Treacy, Aideen E Ryan, Teresa Heinzl, et al.
Stem Cell Research & Therapy
|
April 7, 2021
Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice
Oliver Treacy, Kevin Lynch, Nick Murphy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 5, 2013
Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation
Aideen E Ryan, Paul Lohan, Lisa O'Flynn, et al.
Cancer Immunology Research
|
September 20, 2018
Stromal Cell PD-L1 Inhibits CD8<sup>+</sup> T-cell Antitumor Immune Responses and Promotes Colon Cancer
Grace O'Malley, Oliver Treacy, Kevin Lynch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 13, 2020
TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo
Kevin Lynch, Oliver Treacy, Xizhe Chen, et al.
Oncoimmunology
|
February 8, 2021
Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis
Serika D Naicker, Claire L Feerick, Kevin Lynch, et al.
Iscience
|
September 23, 2024
Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signaling
Niamh A Leonard, Shania M Corry, Eileen Reidy, et al.
Journal for Immunotherapy of Cancer
|
October 19, 2025
Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axis
Aoise O'Neill, Norashikin Zakaria, Courtney Bull, et al.
Cell Reports
|
May 11, 2023
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment
Hannah Egan, Oliver Treacy, Kevin Lynch, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
International Immunopharmacology
|
February 26, 2026
Cyclophosphamide-pomalidomide combination alters the tumour cell secretome and enhances the anti-myeloma activity of elotuzumab through NK cell-mediated cytotoxicity
Claire L Feerick, Lei Lei, Dawn Swan, et al.
Plos One
|
August 11, 2012
Adenoviral transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation
Oliver Treacy, Aideen E Ryan, Teresa Heinzl, et al.
Stem Cell Research & Therapy
|
April 7, 2021
Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice
Oliver Treacy, Kevin Lynch, Nick Murphy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 5, 2013
Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation
Aideen E Ryan, Paul Lohan, Lisa O'Flynn, et al.
Cancer Immunology Research
|
September 20, 2018
Stromal Cell PD-L1 Inhibits CD8<sup>+</sup> T-cell Antitumor Immune Responses and Promotes Colon Cancer
Grace O'Malley, Oliver Treacy, Kevin Lynch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 13, 2020
TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo
Kevin Lynch, Oliver Treacy, Xizhe Chen, et al.
Oncoimmunology
|
February 8, 2021
Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis
Serika D Naicker, Claire L Feerick, Kevin Lynch, et al.
Iscience
|
September 23, 2024
Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signaling
Niamh A Leonard, Shania M Corry, Eileen Reidy, et al.
Journal for Immunotherapy of Cancer
|
October 19, 2025
Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axis
Aoise O'Neill, Norashikin Zakaria, Courtney Bull, et al.
Cell Reports
|
May 11, 2023
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment
Hannah Egan, Oliver Treacy, Kevin Lynch, et al.
Page
of 3